Literature DB >> 23142808

Obesity-related alterations in cardiac lipid profile and nondipping blood pressure pattern during transition to diastolic dysfunction in male db/db mice.

Vincent G Demarco1, David A Ford, Erik J Henriksen, Annayya R Aroor, Megan S Johnson, Javad Habibi, Lixin Ma, Ming Yang, Carolyn J Albert, John W Lally, Caleb A Ford, Mujalin Prasannarong, Melvin R Hayden, Adam T Whaley-Connell, James R Sowers.   

Abstract

Obesity and a nondipping circadian blood pressure (BP) pattern are associated with diastolic dysfunction. Ectopic lipid accumulation is increasingly recognized as an important metabolic abnormality contributing to diastolic dysfunction. However, little is known about the contribution of different lipids and the composition of lipid analytes to diastolic dysfunction. We have performed functional and structural studies and analyzed cardiac lipid profile at two time points during progression to diastolic dysfunction in a genetic model of obesity. Serial cardiac magnetic resonance imaging and telemetric measures of BP between 12 and 15 wk of age in obese male db/db mice indicated a nondipping circadian BP pattern and normal diastolic function at 12 wk that progressed to a deteriorating nondipping pattern and onset of diastolic dysfunction at 15 wk of age. Lipidomic analysis demonstrated elevated fatty acids and ceramides in db/db at 12 wk, but their levels were decreased at 15 wk, and this was accompanied by persistent mitochondrial ultrastructural abnormalities in concert with evidence of increased fatty acid oxidation and enhanced production of reactive oxygen species. Triacylglyceride and diacylglyceride levels were elevated at both 12 and 15 wk, but their composition changed to consist of more saturated and less unsaturated fatty acyl at 15 wk. An increase in the lipid droplets was apparent at both time points, and this was associated with increases in phosphatidycholine. In conclusion, a distinct pattern of myocardial lipid remodeling, accompanied by oxidative stress, is associated with the onset of diastolic dysfunction in obese, insulin-resistant db/db mice.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23142808      PMCID: PMC3529378          DOI: 10.1210/en.2012-1835

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  59 in total

1.  Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation.

Authors:  Liyan Zhang; John R Ussher; Tatsujiro Oka; Virgilio J J Cadete; Cory Wagg; Gary D Lopaschuk
Journal:  Cardiovasc Res       Date:  2010-08-20       Impact factor: 10.787

2.  Role of cardiac steatosis and lipotoxicity in obesity cardiomyopathy.

Authors:  Yingmei Zhang; Jun Ren
Journal:  Hypertension       Date:  2011-01-10       Impact factor: 10.190

3.  A new twist in the function of the cardiac lipid droplet.

Authors:  E Dale Abel
Journal:  Nat Med       Date:  2011-09-07       Impact factor: 53.440

4.  Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging.

Authors:  Hanrui Zhang; Brandon Morgan; Barry J Potter; Lixin Ma; Kevin C Dellsperger; Zoltan Ungvari; Cuihua Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-07-30       Impact factor: 4.733

5.  Analysis of cholesteryl esters and diacylglycerols using lithiated adducts and electrospray ionization-tandem mass spectrometry.

Authors:  John A Bowden; Carolyn J Albert; Omar S Barnaby; David A Ford
Journal:  Anal Biochem       Date:  2011-07-08       Impact factor: 3.365

Review 6.  Lipotoxicity and cardiac dysfunction in mammals and Drosophila.

Authors:  Ryan Tyge Birse; Rolf Bodmer
Journal:  Crit Rev Biochem Mol Biol       Date:  2011-08-19       Impact factor: 8.250

7.  Subclinical regional left ventricular dysfunction in obese patients with and without hypertension or hypertrophy.

Authors:  José L F Santos; Vera M C Salemi; Michael H Picard; Charles Mady; Otávio R Coelho
Journal:  Obesity (Silver Spring)       Date:  2010-10-21       Impact factor: 5.002

8.  Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans.

Authors:  Eugene P Rhee; Susan Cheng; Martin G Larson; Geoffrey A Walford; Gregory D Lewis; Elizabeth McCabe; Elaine Yang; Laurie Farrell; Caroline S Fox; Christopher J O'Donnell; Steven A Carr; Ramachandran S Vasan; Jose C Florez; Clary B Clish; Thomas J Wang; Robert E Gerszten
Journal:  J Clin Invest       Date:  2011-03-14       Impact factor: 14.808

9.  TNF-alpha contributes to endothelial dysfunction in ischemia/reperfusion injury.

Authors:  Cuihua Zhang; Xiangbin Xu; Barry J Potter; Wei Wang; Lih Kuo; Lloyd Michael; Gregory J Bagby; William M Chilian
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-12-29       Impact factor: 8.311

10.  Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity.

Authors:  Suneng Fu; Ling Yang; Ping Li; Oliver Hofmann; Lee Dicker; Winston Hide; Xihong Lin; Steven M Watkins; Alexander R Ivanov; Gökhan S Hotamisligil
Journal:  Nature       Date:  2011-05-01       Impact factor: 49.962

View more
  28 in total

1.  ABCG1 regulates pulmonary surfactant metabolism in mice and men.

Authors:  Thomas Q de Aguiar Vallim; Elinor Lee; David J Merriott; Christopher N Goulbourne; Joan Cheng; Angela Cheng; Ayelet Gonen; Ryan M Allen; Elisa N D Palladino; David A Ford; Tisha Wang; Ángel Baldán; Elizabeth J Tarling
Journal:  J Lipid Res       Date:  2017-03-06       Impact factor: 5.922

2.  ABCG1 is required for pulmonary B-1 B cell and natural antibody homeostasis.

Authors:  Angel Baldan; Ayelet Gonen; Christina Choung; Xuchu Que; Tyler J Marquart; Irene Hernandez; Ingemar Bjorkhem; David A Ford; Joseph L Witztum; Elizabeth J Tarling
Journal:  J Immunol       Date:  2014-10-22       Impact factor: 5.422

Review 3.  The pathophysiology of hypertension in patients with obesity.

Authors:  Vincent G DeMarco; Annayya R Aroor; James R Sowers
Journal:  Nat Rev Endocrinol       Date:  2014-04-15       Impact factor: 43.330

Review 4.  Metabolomics in diabetic complications.

Authors:  Laura A Filla; James L Edwards
Journal:  Mol Biosyst       Date:  2016-02-19

5.  ER phospholipid composition modulates lipogenesis during feeding and in obesity.

Authors:  Xin Rong; Bo Wang; Elisa Nd Palladino; Thomas Q de Aguiar Vallim; David A Ford; Peter Tontonoz
Journal:  J Clin Invest       Date:  2017-08-28       Impact factor: 14.808

6.  Ceramide-Protein Interactions Modulate Ceramide-Associated Lipotoxic Cardiomyopathy.

Authors:  Stanley M Walls; Anthony Cammarato; Dale A Chatfield; Karen Ocorr; Greg L Harris; Rolf Bodmer
Journal:  Cell Rep       Date:  2018-03-06       Impact factor: 9.423

7.  Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice.

Authors:  Brian Bostick; Javad Habibi; Vincent G DeMarco; Guanghong Jia; Timothy L Domeier; Michelle D Lambert; Annayya R Aroor; Ravi Nistala; Shawn B Bender; Mona Garro; Melvin R Hayden; Lixin Ma; Camila Manrique; James R Sowers
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-03-06       Impact factor: 4.733

8.  Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a mouse model of Western diet induced obesity.

Authors:  Brian Bostick; Javad Habibi; Lixin Ma; Annayya Aroor; Nathan Rehmer; Melvin R Hayden; James R Sowers
Journal:  Metabolism       Date:  2014-04-12       Impact factor: 8.694

9.  Rescue of cardiac leptin receptors in db/db mice prevents myocardial triglyceride accumulation.

Authors:  Michael E Hall; Matthew W Maready; John E Hall; David E Stec
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-06-17       Impact factor: 4.310

10.  Diabetes mellitus and vascular disease.

Authors:  James R Sowers
Journal:  Hypertension       Date:  2013-05       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.